Bedrocan · CBD-dominant

Bedrolite

Bred by Bedrocan BV.

THC0.4% THCCBD9% CBDCultivationIndoor hydroponic
Bedrolite — botanical reference image
Educational reference. Not medical advice. Medical cannabis is a prescription-only medicine in the UK — consult a specialist clinician.

History & Producer

Origin

High-CBD, low-THC cultivar often prescribed for paediatric epilepsy and severe anxiety.

Genetics

Lineage

CBD-rich hybrid

Indica 60%Sativa 40%

Cannabinoid & Production Profile

Specifications

THC
0.4% THC
CBD
9% CBD
Classification
CBD-dominant
Cultivation
Indoor hydroponic
Irradiation
Gamma

Dominant Terpenes

Aromatic Compounds

  • Myrcene0.52%
  • Linalool0.31%
  • Pinene0.18%

Sensory Profile

Appearance, Flavour & Aroma

Appearance

Open, airy buds in pale sage green.

Flavour

Soft herbal, hay and mild lemon.

Aroma

Hay, fresh herb.

Reported Effects

Effect Profile

Aggregated from patient diaries and prescriber feedback. Intensity is relative within this strain's profile, not an absolute clinical measure.

Calm84%
Clear-headed74%
Relaxed68%
Anti-inflammatory72%
Focused60%

Condition Recommendations

Discussed Indications

  • Treatment-resistant epilepsy

    Evidence · Emerging

    High-CBD low-THC cultivars are the most-studied cannabis-derived intervention for refractory epilepsy.

    Strong fit
  • Generalised anxiety

    Evidence · Limited

    Low THC keeps the cultivar suitable for THC-naive patients.

    Strong fit
  • Inflammatory conditions

    Evidence · Limited

    CBD is discussed in the literature for inflammatory pathways.

    Moderate fit
  • Acute pain

    Evidence · Anecdotal

    CBD-dominant cultivars are not typically first-line for severe pain.

    Caution

Not a substitute for a prescriber's assessment. Suitability depends on tolerance, comorbidities and concomitant medication.